Léčba erlotinibem nemocných s nemalobuněčnými karcinomy plic - efekt snížené dávky při závažných nežádoucích účincích

Title in English Treatment of NSCLC patients with erlotinib. The effect of reduced dose in severe adverse effects.
Authors

PEŠEK Miloš KREJČÍ Jana SKŘIČKOVÁ Jana ZATLOUKAL P.

Year of publication 2009
Type Article in Proceedings
Conference Abstrakty XVII. Západočeské pneumoonkologické dny
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords erlotinib; reduced dose; NSCLC treatment
Description The authors outline the effect of a reduced dose of erlotinib in treatment of NSCLC patients if adverse effects force us to reduce the dose of erlotinib.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info